Celera Sees Slightly Stronger Revenue, Narrowed Loss in Q4

Jul 25, 2002

NEW YORK, July 25 - Celera Genomics today said that its fiscal fourth-quarter loss narrowed as the severe staff cutsimplemented last month to help push the company downstream began to pay off.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Already have an account?
Login Now.

Breaking News

iCubate Receives CE Mark for Platform, Bloodstream Infection Assay
Caprion Collaborating with FNIH on Alzheimer's Biomarkers
Jennifer Doudna, Feng Zhang Awarded NHGRI Grants for CRISPR-Based Research
BRCA1/2 LOH Testing May Offer Treatment Response Clues in Some Cancer Cases
Mass General, CRISPR Therapeutics to Develop Cancer Therapies
Jackson Laboratory Team Wins $2.1M NIH Grant to Develop RNA Analysis Tech

The Scan

This Week in Cell

In Cell this week: regulatory changes in pancreatic cancer, metabolic shifts in Alzheimer's disease, and more.

Out of the Books

NPR reports that Turkish high school students will no longer study evolution.

Mountainside Sequencing

Researchers report they sequenced and identified plant species in an "al fresco" laboratory.

Better Treatments Sought

An Australian team searches for genetic alterations linked to depression in hopes of developing personalized treatments, the Sydney Morning Herald reports.

Main menu